Wednesday, July 12, 2017

Book: Alkaline Diet: A Complete Guide For Alkaline Diet, Health Benefits of the Alkaline Diet: What To Eat & What To Avoid and How to Check Your Acidic Levels? ... Eating, Optimal Health, Lose Weight Book 1) by Anas Malla


The Perfect Balance...

We can see that there are so many diets available to us. Each diet has its benefits, but each also comes with its downsides. Now, when you think about different diets and choosing the ideal one for you, the word balance comes to your mind. If you are looking for a diet offering you the perfect balance, it’s the alkaline diet.

We will talk later about how this diet works, but the important thing to know is that it keeps pH levels throughout your body balanced. That, in turn, secured that your organism reaches the optimum state and, therefore, optimum health. Aside from being able to help you get your weight in order, alkaline diet will assist you in dealing with some annoying health issues, such as chronic pain and other illnesses.

What to Expect:

  • What is alkaline diet and how it works – explaining the principles of eating alkaline-promoting food and properly keeping the acid-alkaline balance in your body

  • How to check your acidic levels – higher levels of acid may cause numerous health problems. Fortunately, it’s easy to keep track of your acidic levels if you follow the simple directions in this book

  • Health benefits and risks of the alkaline diet – the alkaline style of life has numerous advantages for both physical and mental health, but the most important benefit is that it provides an entirely natural way to lose extra pounds and MAINTAIN them. We will also cover some risks of the diet to make sure everything goes the way it should.

  • Mistakes beginners often make – my goal is to show you how to apply the alkaline diet concept to your life successfully. The best way to do that is to analyze what mistakes beginners often make so that you can learn from them

  • Foods to eat and avoid – each diet has its go-to foods that are a must and the foods that you should make sure to avoid. The “Alkaline Diet” book will recommend you which foods you should consume and which you should avoid, as well as offer some tips on how to combine your food. Another mystery that we will solve is whether you should drink alkaline water during your diet.

And much more!!

Book: The Cancer Fighting Cook by Richard Lombardi


The Cancer-Fighting Cook Cookbook features a variety of recipes and heartwarming stories from Chef's around the world. Each flavorful recipe includes a specific caner fighting ingredient to help provide patients with the necessary nutrition they need before, during and after treatment.
As a cancer survivor himself, Richard Lombardi has created this cookbook to help patients and caregivers prepare nutrient rich recipes that combat the symptoms caused by treatment and enhance the recovery process.
Each delicious recipe includes a specific cancer fighting ingredient and provides nutritional information. We've also included helpful hints, kitchen basics and a removable list of beneficial ingredients for quick reference.
All recipes included in this cookbook come from Richard's own collection and professional chefs from around the world. They have shared these recipes and stories in hopes of providing savory meals that truly help the healing process and to encourage patients throughout their cancer journey.

Tuesday, July 11, 2017

Book: Keto for Cancer: Ketogenic Metabolic Therapy as a Targeted Nutritional Strategy by Miriam Kalamian EdM MS CNS and Thomas N. Seyfried


A Comprehensive Guide for Patients and Practitioners
Although evidence supporting the benefits of ketogenic diet therapies continues to mount, there is little to guide those who wish to adopt this diet as a metabolic therapy for cancer. Keto for Cancer fills this need. Inspired by the work of Dr. Thomas N. Seyfried, PhD, nutritionist Miriam Kalamian has written the first book to lay out comprehensive guidelines that specifically address the many challenges associated with cancer, and particularly the deep nutritional overhaul involved with the ketogenic diet.
Kalamian, a leading voice in the keto movement, is driven by passion from her own experience in using the ketogenic diet for her young son. Her book addresses the nuts and bolts of adopting the diet, from deciding whether keto is the right choice to developing a personal plan for smoothly navigating the keto lifestyle. It is invaluable for both beginners and seasoned users of the ketogenic diet, as well as for health-care professionals who need a toolkit to implement this targeted metabolic therapy.
The book guides readers to a deeper understanding of the therapeutic potential of the ketogenic diet―which extends well beyond simply starving cancer―emphasizing the powerful impact the diet has on the metabolism of cancer cells. Nutritional nuances are explored in sections such as “Fasting Protocols” and “Know What’s in the Foods You Eat” while meal templates and tracking tools are provided in “Preparing Keto Meals.”
Kalamian also discusses important issues such as self-advocacy. Readers of Keto for Cancer are empowered to “get off the bench and get in the game.” To that end, Kalamian offers tips on how to critically examine cancer-care options then incorporate what resonates into a truly personalized treatment plan.

Book: Outside the Box Cancer Therapies: Alternative Therapies That Treat and Prevent Cancer by Mark Stengler and Paul Anderson

Naturopathic medical doctors Mark Stengler and Paul Anderson focus on the most critical components of Integrative Oncology Care. Using an accessible, case-history approach, they explore the different types of cancer, the causes of cancer, how proper nutrition can help prevent and treat cancer, the most well-studied supplement to use with cancer treatment, cutting-edge therapies (such as intravenous high dose vitamin C and other studied therapies), and natural solutions to common problems (such as the side effects of chemotherapy and radiation).

Monday, July 10, 2017

Malignant mesothelioma

Malignant mesothelioma is a disease in which malignant (cancer) cells form in the thin layer of tissue that covers the lung, chest wall, or abdomen. It may also form in the heart or testicles, but this is rare.
The type of malignant mesothelioma depends on the cell in which it began. The most common type of malignant mesothelioma is epithelial mesothelioma, which forms in the cells that line organs. The other types begin in spindle-shaped cells called sarcomatoid cells or are a mixture of both cell types. Epithelial mesothelioma may grow more slowly and have a better prognosis than other types.
The major cause of malignant mesothelioma is being exposed to asbestos over a period of time. This includes people who were exposed to asbestos in the workplace and their family members.
After a person is exposed to asbestos, it usually takes at least 20 years for malignant mesothelioma to form.

(Souce: NCI)

The Cancer-Fighting Kitchen, Second Edition: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery by Rebecca Katz and Mat Edelson

This new and revised edition of the IACP award-winning cookbook brings the healing power of delicious, nutritious foods to those whose hearts and bodies crave a revitalizing meal, through 150 new and updated recipes.

Featuring science-based, nutrient-rich recipes that are easy to prepare and designed to give patients a much-needed boost by stimulating appetite and addressing treatment side effects including fatigue, nausea, dehydration, mouth and throat soreness, tastebud changes, and weight loss. A step-by-step guide helps patients nutritionally prepare for all phases of treatment, and a full nutritional analysis accompanies each recipe. This remarkable resource teaches patients and caregivers how to use readily available powerhouse ingredients to build a symptom- and cancer-fighting culinary toolkit. Blending fantastic taste and meticulous science, these recipes for soups, vegetable dishes, proteins, and sweet and savory snacks are rich in the nutrients, minerals, and phytochemicals that help patients thrive during treatment. 

This second edition also includes a dozen new recipes--many of which are simpler and less complicated, for cancer patients to prepare on their low days--as well as a list of cancer-fighting foods that can be incorporated into everyday life without stepping behind the stove. Rebecca has also revised the text with the most up-to-date scientific research and includes a section on how friends and family can build a culinary support team.

Book: Anticancer: A New Way of Life Hardcover by David Servan-Schreiber

Anticancer has been a bestselling phenomenon since Viking first published it in fall 2008. Now, a new edition addresses current developments in cancer research and offers more tips on how people living with cancer can fight it and how healthy people can prevent it. The new edition of Anticancer includes: 

• The latest research on anticancer foods, including new alternatives to sugar and cautions about some that are now on the market 
• New information about how vitamin D strengthens the immune system 
• Warnings about common food contaminants that have recently been proven to contribute to cancer progression 
• A new chapter on mind-body approaches to stress reduction, with recent studies that show how our reactions to stress can interfere with natural defenses and how friendships can support healing in ways never before understood 
• A groundbreaking study showing that lifestyle modification, as originally proposed in Anticancer, reduces mortality for breast cancer by an astounding 68 percent after completion of treatment 
• New supporting evidence for the entire Anticancer program 

Sunday, July 9, 2017

How can I find skin cancer early?

  • Talk with your doctor if you see any changes on your skin that do not go away within one month.
  • Check the skin on all surfaces of your body, even in your mouth.
  • Watch for a new mole or other new growth on your skin.
  • Check for changes in the appearance of an old growth on the skin or scar (especially a burn scar).
  • Watch for a patch of skin that is a different color and becomes darker or changes color.
  • Watch for a sore that does not heal – it may bleed or form a crust.
  • Check your nails for a dark band. Check with your doctor if you see changes, such as if the dark band begins to spread.

When skin cancer is found early, it can be treated more easily.

Saturday, July 8, 2017

Although dark skin does not burn in the sun as easily as fair skin, everyone is at risk for skin cancer. Even people who don't burn are at risk for skin cancer. It doesn't matter whether you consider your skin light, dark, or somewhere in between. You are at risk for skin cancer. Being in the sun can damage your skin. Sunlight causes damage through ultraviolet, or UV rays, (they make up just one part of sunlight). Two parts of UV, UVA and UVB, can both cause damage to skin. Also, the sun isn't the only cause of skin cancer. There are other causes. That's why skin cancer may be found in places on the body never exposed to the sun.

Is it true that only people with light skin get skin cancer?

No. Anyone can get skin cancer. It's more common among people with a light (fair) skin tone, but skin cancer can affect anyone. Skin cancer can affect both men and women. Even teenagers and, rarely, younger children can develop skin cancer.

How can I protect myself from skin cancer?

Have your doctor check your skin if you are concerned about a change. Your doctor may take a sample of your skin to check for cancer cells.

Ask your doctor about your risk of skin cancer:
  • Some skin conditions and certain medicines (such as some antibiotics or hormones) may make your skin more sensitive to damage from the sun.
  • Medicines or medical conditions (such as HIV) that suppress the immune system may make you more likely to develop skin cancer.
  • Having scars or skin ulcers increases your risk.
  • Exposure to a high level of arsenic (a poison that is sometimes found in well water or pesticides) increases your risk.

Stay out of the sun as much as you can. Whenever possible, avoid exposure to the sun from
10 a.m. to 4 p.m. If you work or play outside, then…
  • Try to wear long sleeves, long pants, and a hat that shades your face, ears, and neck with a brim all around.
  • Use sunscreen with a label that says it is broad spectrum or is at least SPF 15 and can filter both UVA and UVB rays.
  • Wear sunglasses that filter UV to protect your eyes and the skin around your eyes.
  • If you are concerned about having a low level of vitamin D from not being in the sun, talk with your doctor about supplements.

Don't use tanning beds, tanning booths, or sunlamps.

Sunday, June 25, 2017

Technologies Enhance Tumor Surgery

Helping Surgeons Spot and Remove Cancer

For surgeons, removing a tumor is a balancing act. Cut out too much and you risk removing healthy tissues that have important functions. Remove too little and you may leave behind cancer cells that could grow back into a tumor over time.

NIH-funded researchers are developing new technologies to help surgeons determine exactly where tumors end and healthy tissue begins. Their ultimate goal is to make surgery for cancer patients safer and more effective.

“Currently, surgeons view MRI and CT scans taken prior to an operation to establish where a tumor is located and to plan a surgical approach that will minimize damage to healthy tissues,” says Dr. Steven Krosnick, an NIH expert in image-guided surgery. “But once the operation has begun, surgeons generally rely only on their eyes and sense of touch to distinguish tumor from healthy tissue.”

Surgeons go through many years of training to understand the subtle cues that can distinguish tumor from normal surroundings. Sometimes the tumor is a slightly different color than healthy tissue, or it feels different. It might also bleed more readily or could contain calcium deposits. Even with these cues, however, surgeons don’t always get it right.

“In a lot of cases, we leave tumor behind that could be safely removed if only we were able to better visualize it,” says Dr. Daniel Orringer, a neurosurgeon at the University of Michigan.

In today’s operating rooms, pathologists can often help surgeons determine if all of a tumor has been taken out. A pathologist may view the edges of the tissue under a microscope and look for cancer cells. If they’re found, the surgeon will remove more tissue from the patient and send these again to the pathologist for review. This process can occur repeatedly while the patient remains on the operating table and continue until no cancer cells are detected.

“Each time a pathologist analyzes tissue during an operation, it can take up to 30 minutes because the tissue has to be frozen, thinly sliced, and stained so it can be viewed under the microscope,” Krosnick says. “If multiple rounds of tissue are taken, it can greatly increase the length of the surgery.”

In the days following an operation, the pathologist conducts a more thorough review of the tissue. If cancer cells are found at the margins, the patient may undergo a second surgery to remove cancer that was left behind.

Orringer is part of a research team that’s testing a new technology that could help surgeons tell the difference between a tumor and healthy brain tissue during surgery. The team developed a special microscope with NIH support that shoots a pair of low-energy lasers at the tissue. That causes the chemical bonds in the tissue’s molecules to vibrate. The vibrations are then analyzed by a computer and used to create detailed images of the tissue.

From a molecular point of view, the components of a tumor differ from those in healthy tissue. This specialized microscope can reveal differences between the tissues that can’t be seen with the naked eye.

“Our technology enables us to get a microscopic view of human tissues without taking them out of the body,” Orringer says. “We can see cells, blood vessels, the connections between brain cells…all of the microscopic components that make up the brain.”

Orringer and colleagues developed a computer program that can quickly analyze the images and assess whether or not cancer cells are present. This type of analysis could help surgeons decide whether all of a tumor has been cut out. To date, Orringer has used the specialized microscope to help remove cancer tissue in nearly 100 patients with brain tumors.

Other researchers are taking different approaches. For example, Dr. Quyen Nguyen—a head and neck surgeon at the University of California, San Diego—has developed a fluorescent molecule that’s currently being tested in clinical trials. The patient receives an injection of the molecules before surgery. When exposed to certain types of light, these molecules cause cancer cells to glow, making them easier to spot and remove. The surgeon then uses a near-infrared camera to visualize the glowing tumor cells while operating.

Nguyen is also developing a fluorescent molecule to light up nerves. Accidental nerve injury during surgery can leave patients with loss of movement or feeling. In some cases, sexual function may be impaired.

“Nerves are really, really small, and they’re often buried in soft tissue or encased within bone. When we have to do cancer surgery, they can be encased in the cancer itself,” Nguyen says. The fluorescent molecule could help surgeons detect hard-to-spot nerves, so they can be protected. The nerve-tagging molecule is now being tested in animal studies.

Other NIH-funded researchers are focusing on ways to speed up cancer surgeries. Dr. Milind Rajadhyaksha, a researcher at Memorial Sloan Kettering Cancer Center, has developed a microscope technique to reduce the amount of time it takes to perform a common surgery for removing non-melanoma skin cancers.

Each year about 2 million people in the U.S. undergo Mohs surgery, in which a doctor successively removes suspicious areas until the surrounding skin tissue is free of cancer. The procedure can take several hours, because each time more tissue is removed, it has to be prepared and reviewed under a microscope to determine if cancer cells remain. This step can take up to 30 minutes.

The technique developed by Rajadhyaksha shortens the time for assessing removed tissue to less than 5 minutes, which greatly reduces the overall length of the procedure. Tissue is mounted in a specialized microscope that uses a focused laser line to do multiple scans of the tissue. The resulting image “strips” are then combined, like a mosaic, into a complete microscopic image of the tissue.

About 1,000 specialized skin surgeries have already been performed guided by this technique. Rajadhyaksha is currently developing an approach that would allow doctors to use the technology directly on a patient’s skin, before any tissue has been removed. This would allow doctors to identify the edges of tumors before the start of surgery and reduce the need for several pre-surgical “margin-mapping” biopsies.

There are many types of cancer surgeries, and researchers continue to work hard to develop better techniques. If you’re considering surgery to treat your cancer, you can find additional information at this NIH Cancer Surgerypage.



Detection of human brain tumor infiltration with quantitative stimulated Raman scattering microscopy. Ji M, Lewis S, Camelo-Piragua S, Ramkissoon SH, et al. Sci Transl Med. 2015 Oct 14;7(309):309ra163. doi: 10.1126/scitranslmed.aab0195. PMID: 26468325.

Fluorescence-guided surgery with live molecular navigation--a new cutting edge. Nguyen QT, Tsien RY. Nat Rev Cancer. 2013 Sep;13(9):653-62. doi: 10.1038/nrc3566. Epub 2013 Aug 8. Review. PMID: 23924645.

Intraoperative imaging during Mohs surgery with reflectance confocal microscopy: initial clinical experience.Flores ES, Cordova M, Kose K, et al. M. J Biomed Opt. 2015 Jun;20(6):61103. doi: 10.1117/1.JBO.20.6.061103. PMID: 25706821.

Sensitivity and specificity for detecting basal cell carcinomas in Mohs excisions with confocal fluorescence mosaicing microscopy. Gareau DS, Karen JK, Dusza SW, et al. J Biomed Opt. 2009 May-Jun;14(3):034012. doi: 10.1117/1.3130331. PMID: 19566305.

Thursday, June 8, 2017

acidification

The process of making or becoming an acid. An acid is a substance that gives off hydrogen ions in water and forms salts by combining with certain metals.

acid-base equilibrium

In medicine, the state of having the right amount of acid and base in the blood and other body fluids. Keeping a normal acid-base equilibrium is important for the body to work the way it should. Also called acid-base balance.

acid-base balance

In medicine, the state of having the right amount of acid and base in the blood and other body fluids. Keeping a normal acid-base balance is important for the body to work the way it should. Also called acid-base equilibrium.

acid

A chemical that gives off hydrogen ions in water and forms salts by combining with certain metals. Acids have a sour taste and turn certain dyes red. Some acids made by the body, such as gastric acid, can help organs work the way they should. An example of an acid is hydrochloric acid. Acidity is measured on a scale called the pH scale. On this scale, a value of 7 is neutral, and a pH value of less than 7 to 0 shows increasing acidity.

achlorhydria

A lack of hydrochloric acid in the digestive juices in the stomach. Hydrochloric acid helps digest food.

ACF

Clusters of abnormal tube-like glands in the lining of the colon and rectum. ACF form before colorectal polyps and are one of the earliest changes that can be seen in the colon that may lead to cancer. Also called aberrant crypt foci.

acetyl-L-carnitine hydrochloride

A form of the natural substance carnitine that is being studied as a way to prevent tissue damage caused by chemotherapy. Carnitine is made in muscle and liver tissue and is found in certain foods, such as meat, poultry, fish, and some dairy products. It is used by many cells in the body to make energy from fat. Also called acetyl-L-carnitine and ALCAR.

acetyl-L-carnitine

A form of the natural substance carnitine that is being studied as a way to prevent tissue damage caused by chemotherapy. Carnitine is made in muscle and liver tissue and is found in certain foods, such as meat, poultry, fish, and some dairy products. It is used by many cells in the body to make energy from fat. Also called acetyl-L-carnitine hydrochloride and ALCAR.

acetylcysteine

A drug usually used to reduce the thickness of mucus and ease its removal. It is also used to reverse the toxicity of high doses of acetaminophen. Also called N-acetyl-L-cysteine and N-acetylcysteine.

acetylcholine

A chemical made by some types of nerve cells. It is used to send messages to other cells, including other nerve cells, muscle cells, and gland cells. It is released from the nerve ending and carries signals to cells on the other side of a synapse (space between nerve cells and other cells). Acetylcholine helps control memory and the action of certain muscles. It is a type of neurotransmitter.

acetylation

A chemical reaction in which a small molecule called an acetyl group is added to other molecules. Acetylation of proteins may affect how they act in the body.

acetyl group

A small molecule made of two carbon, three hydrogen, and one oxygen atoms. Acetyl groups are added to or removed from other molecules and may affect how the molecules act in the body.

acetone

A chemical substance found naturally in small amounts in plants, trees, volcanoes, and forest fires. Acetone is also made by the body when fats are broken down. It is also found in tobacco smoke, car exhaust, and trash landfills. In industry, acetone is used in some plastics, fibers, medicines, household cleaners, glues, and nail polish removers. Being exposed to high levels of acetone may irritate the skin, eyes, nose, throat, and lungs. It can cause headaches, nausea, vomiting, dizziness, confusion, loss of consciousness, and other health problems.

acetic acid

    An acid found in vinegar. Acetic acid is also used to dissolve substances needed to make some medicines and other products, such as plastics.

acetate

A form of acetic acid (an acid found in vinegar).

acetaminophen

A drug that reduces pain and fever (but not inflammation). It belongs to the family of drugs called analgesics.

ACE inhibitor

A drug that is used to lower blood pressure. An ACE inhibitor is a type of antihypertensive agent. Also called angiotensin-converting enzyme inhibitor.

Accolate

A drug used to prevent and treat symptoms of asthma. It blocks substances that cause inflammation in the lungs. It is a type of antiasthmatic agent and a leukotriene receptor antagonist. Also called zafirlukast

accelerated-fraction radiation therapy

Radiation treatment in which the total dose of radiation is divided into small doses and the treatments are given more than once a day. The total dose of radiation is also given over a shorter period of time (fewer days) compared to standard radiation therapy.

accelerated radiation therapy

Radiation treatment in which the total dose of radiation is given over a shorter period of time (fewer days) compared to standard radiation therapy.

accelerated phase chronic myelogenous leukemia

A phase of chronic myelogenous leukemia in which the disease is progressing. In this phase, 10% to 19% of the cells in the blood and bone marrow are blast cells (immature blood cells).

accelerated partial-breast irradiation

A type of radiation therapy given only to the part of the breast that has cancer in it. Accelerated partial-breast irradiation gives a higher dose over a shorter time than is given in standard whole-breast radiation therapy. Accelerated partial-breast irradiation may be given using internal or external sources of radiation. Also called partial-breast irradiation.

ACAPHA

A mixture of six herbs that has been used in China to prevent and treat diseases such as lung and esophageal cancers. It is being studied in the United States and Canada in the prevention of lung cancer in people who used to smoke.

AC regimen

An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer, including breast cancer that has spread or come back. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide. Also called AC.

AC

An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer, including breast cancer that has spread or come back. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide. Also called AC regimen.

ABX-EGF

A human monoclonal antibody that is being used to treat colorectal cancer that has spread to other parts of the body. It is used in patients whose disease has not gotten better during or after treatment with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. ABX-EGF binds to the epidermal growth factor receptor (EGFR) and may block tumor cell growth. Also called panitumumab and Vectibix.

ABVE-PC regimen

An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide. Also called ABVE-PC, DBVE-PC, and DBVE-PC regimen.

ABVE-PC

An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide. Also called ABVE-PC regimen, DBVE-PC, and DBVE-PC regimen.

ABVE regimen

An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, and etoposide. Also called ABVE, DBVE, and DBVE regimen.

ABVE

An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, and etoposide. Also called ABVE regimen, DBVE, and DBVE regimen.

ABVD regimen

An abbreviation for a chemotherapy combination used to treat Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vinblastine sulfate, and dacarbazine. Also called ABVD.

ABVD

An abbreviation for a chemotherapy combination used to treat Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vinblastine sulfate, and dacarbazine. Also called ABVD regimen.

ABT-888

A substance being studied in the treatment of breast cancers caused by mutations (changes) in the BRCA1 and BRCA2 genes. It is also being studied in the treatment of other types of cancer. It blocks an enzyme involved in many functions of the cell, including the repair of DNA damage. DNA damage may be caused by normal cell actions, UV light, some anticancer drugs, and radiation used to treat cancer. ABT-888 may cause cancer cells to die. It is a type of poly(ADP-ribose) polymerase inhibitor. Also called PARP-1 inhibitor ABT-888 and veliparib.

ABT-869

A substance being studied in the treatment of several types of cancer. ABT-869 blocks the action of several growth factors. It may also block the growth of new blood vessels that tumors need to grow and may cause cancer cells to die. It is a type of receptor tyrosine kinase inhibitor and a type of angiogensis inhibitor. Also called multitargeted receptor tyrosine kinase inhibitor ABT-869.

ABT-751

A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called sulfonamides.

ABT-510

A substance being studied in the treatment of cancer. It is a type of angiogenesis inhibitor

ABT-263

A substance being studied in the treatment of lymphomas and other types of cancer. It blocks some of the enzymes that keep cancer cells from dying. It is a type of Bcl-2 family inhibitor. Also called navitoclax.

absorption

The process of taking nutrients from the digestive system into the blood so they can be used in the body.

absolute risk

A measure of the risk of a certain event happening. In cancer research, it is the likelihood that a person who is free of a specific type of cancer at a given age will develop that cancer over a certain period of time. For example, a woman 35 years of age, with no known risk factors for breast cancer, has an absolute risk of getting breast cancer over a lifetime of 90 years of about 13.5%, meaning one out of every seven women will develop breast cancer.

absolute neutrophil count

A measure of the number of neutrophils in the blood. Neutrophils are a type of white blood cell. They help the body fight infection. An absolute neutrophil count may be used to check for infection, inflammation, leukemia, and other conditions. The lower a person's absolute neutrophil count is, the higher the risk is of getting an infection. Having an absolute neutrophil count of less than 500 means there is a high risk of getting an infection. Cancer treatment, such as chemotherapy, may reduce the absolute neutrophil count. Also called ANC.

Angiogenesis Inhibitors: What is angiogenesis?

What is angiogenesis?

Angiogenesis is the formation of new blood vessels. This process involves the migration, growth, and differentiation of endothelial cells, which line the inside wall of blood vessels.

The process of angiogenesis is controlled by chemical signals in the body. These signals can stimulate both the repair of damaged blood vessels and the formation of new blood vessels. Other chemical signals, called angiogenesis inhibitors, interfere with blood vessel formation. Normally, the stimulating and inhibiting effects of these chemical signals are balanced so that blood vessels form only when and where they are needed.

abscess

An enclosed collection of pus in tissues, organs, or confined spaces in the body. An abscess is a sign of infection and is usually swollen and inflamed.

Abrikossoff tumor

A rare type of soft tissue tumor that usually begins in Schwann cells (cells that hold nerve cells in place). It can occur anywhere in the body, but it usually occurs in or under the skin of the head and neck (especially the mouth or tongue). It may also occur in the chest, breast, esophagus, stomach, or other internal organ. Most Abrikossoff tumors are benign (not cancer), but some may be malignant (cancer) and spread quickly to nearby tissue. They usually occur in middle-aged adults. Also called granular cell tumor.

Abraxane

A drug used to treat breast cancer that has come back or spread to other parts of the body. It is also used with carboplatin to treat advanced non-small cell lung cancer in patients who are not able to have surgery or radiation therapy. It is also used with gemcitabine hydrochloride to treat pancreatic cancer that has spread to other parts of the body. It is being studied in the treatment of other types of cancer. Abraxane is a form of the anticancer drug paclitaxel and may cause fewer side effects than paclitaxel. It stops cancer cells from growing and dividing, and may kill them. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called ABI-007, nanoparticle paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, and protein-bound paclitaxel

ABR test

A test used to detect some types of hearing loss, such as hearing loss caused by injury or tumors that affect nerves involved in hearing. Electrodes are placed on the head and certain tones or clicking sounds are made. The electrodes measure nerve signals in the brain when it reacts to the sounds. Also called auditory brain stem response test, BAER test, and brain stem auditory evoked response test.

ABO blood group system

A system used to group human blood into different types, based on the presence or absence of certain markers on the surface of red blood cells. The four main blood types are A, B, O, and AB. For a blood transfusion, the ABO blood group system is used to match the blood type of the donor and the person receiving the transfusion. People with blood type O can donate blood to anyone and are called universal donors. People with blood type AB can accept blood from all donors and are called universal recipients. People with type A or B can receive matching blood or type O blood.

abnormal

Not normal. Describes a state, condition, or behavior that is unusual or different from what is considered normal. An abnormal lesion or growth in or on the body may be benign (not cancer), precancerous or premalignant (likely to become cancer), or malignant (cancer).

ablation

In medicine, the removal or destruction of a body part or tissue or its function. Ablation may be performed by surgery, hormones, drugs, radiofrequency, heat, or other methods.

abiraterone acetate

A drug used with prednisone to treat prostate cancer that has spread to other parts of the body and has not gotten better with other hormone therapy. It is also being studied in the treatment of other types of cancer. Abiraterone acetate lowers the amount of androgens (male hormones), such as testosterone, made by the body. This may stop the growth of cancer cells that need androgens to grow. Abiraterone acetate is a type of antiandrogen. Also called Zytiga.

ABI-007

A drug used to treat breast cancer that has come back or spread to other parts of the body. It is also used with carboplatin to treat advanced non-small cell lung cancer in patients who are not able to have surgery or radiation therapy. It is also used with gemcitabine hydrochloride to treat pancreatic cancer that has spread to other parts of the body. It is being studied in the treatment of other types of cancer. ABI-007 is a form of the anticancer drug paclitaxel and may cause fewer side effects than paclitaxel. It stops cancer cells from growing and dividing, and may kill them. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called Abraxane, nanoparticle paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, and protein-bound paclitaxel.

aberrant crypt foci

Clusters of abnormal tube-like glands in the lining of the colon and rectum. Aberrant crypt foci form before colorectal polyps and are one of the earliest changes that can be seen in the colon that may lead to cancer. Also called ACF.

Abegrin

A substance being studied in the treatment of some types of cancer and other conditions. Abegrin binds to a protein on the surface of blood vessels and may prevent the growth of new blood vessels that tumors need to grow. It may also prevent the spread of cancer. It is a type of antiangiogenesis agent, a type of metastasis inhibitor, and a type of monoclonal antibody. Also called etaracizumab, humanized monoclonal antibody MEDI-522, and MEDI-522.

abdominoperineal resection

Surgery to remove the anus, the rectum, and part of the sigmoid colon through an incision made in the abdomen. The end of the intestine is attached to an opening in the surface of the abdomen and body waste is collected in a disposable bag outside of the body. This opening is called a colostomy. Lymph nodes that contain cancer may also be removed during this operation.

abdominal x-ray

An x-ray of the organs inside the abdomen. An x-ray is a type of radiation that can pass through the body and onto film, making pictures of areas inside the body. X-rays may be used to help diagnose disease.

abdominal ultrasound

A procedure used to examine the organs in the abdomen. An ultrasound transducer (probe) is pressed firmly against the skin of the abdomen. High-energy sound waves from the transducer bounce off tissues and create echoes. The echoes are sent to a computer, which makes a picture called a sonogram. Also called transabdominal ultrasound.

abdominal

Having to do with the abdomen, which is the part of the body between the chest and the hips that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs.

abdomen

The area of the body that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs.

ABCD rating

A staging system for prostate cancer that uses ABCD. “A” and “B” refer to cancer that is confined to the prostate. “C” refers to cancer that has grown out of the prostate but has not spread to lymph nodes or other places in the body. “D” refers to cancer that has spread to lymph nodes or to other places in the body. Also called Jewett staging system and Whitmore-Jewett staging system.

ABCA1 pathway

Describes a group of proteins in a cell that work together to help remove extra cholesterol and certain fats from tissue in the body. Changes in the ABCA1 pathway may lead to diseases of the heart and blood vessels. Drugs or substances that affect this pathway are being studied in the prevention and treatment of some diseases.

abarelix

A drug used to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available. It belongs to the family of drugs called gonadotropin-releasing hormone (GnRH) antagonists. Also called Plenaxis.

AAP

An enzyme that is normally found in healthy kidneys. It may be found at high levels in the urine when there are kidney problems. It is used as a biomarker to detect damage to the kidneys caused by drugs and other agents. It may also be used to diagnose certain kidney and liver disorders. Also called alanine aminopeptidase.

A6

A substance being studied in the treatment of cancer. A6 is a small piece of a protein called urokinase (an enzyme that dissolves blood clots or prevents them from forming). It is a type of antiangiogenesis agent and a type of antimetastatic agent. Also called urokinase plasminogen activator (uPA)-derived peptide A6.

A33

A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.

Cancer Statistics

Cancer has a major impact on society in the United States and across the world. Cancer statistics describe what happens in large groups of people and provide a picture in time of the burden of cancer on society. Statistics tell us things such as how many people are diagnosed with and die from cancer each year, the number of people who are currently living after a cancer diagnosis, the average age at diagnosis, and the numbers of people who are still alive at a given time after diagnosis. They also tell us about differences among groups defined by age, sex, racial/ethnic group, geographic location, and other categories.

Types of Cancer: Brain and Spinal Cord Tumors

There are different types of brain and spinal cord tumors. These tumors are named based on the type of cell in which they formed and where the tumor first formed in the central nervous system. For example, an astrocytic tumor begins in star-shaped brain cells called astrocytes, which help keep nerve cells healthy. Brain tumors can be benign (not cancer) or malignant (cancer).

Astrocyte: A large, star-shaped cell that holds nerve cells in place and helps them develop and work the way they should. An astrocyte is a type of glial cell.

Other Types of Tumors

Germ Cell Tumors

Germ cell tumors are a type of tumor that begins in the cells that give rise to sperm or eggs. These tumors can occur almost anywhere in the body and can be either benign or malignant.
Our page of cancers by body location/system includes a list of germ cell tumors with links to more information.

Neuroendocrine Tumors

Neuroendocrine tumors form from cells that release hormones into the blood in response to a signal from the nervous system. These tumors, which may make higher-than-normal amounts of hormones, can cause many different symptoms. Neuroendocrine tumors may be benign or malignant.
Our definition of neuroendocrine tumors has more information. 

Neuroendocrine tumor: A tumor that forms from cells that release hormones into the blood in response to a signal from the nervous system. Neuroendocrine tumors may make higher-than-normal amounts of hormones, which can cause many different symptoms. These tumors may be benign (not cancer) or malignant (cancer). Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, medullary thyroid cancer, pheochromocytomas, neuroendocrine carcinoma of the skin (Merkel cell cancer), small cell lung cancer, and large cell neuroendocrine carcinoma (a rare type of lung cancer).

Carcinoid Tumors

Carcinoid tumors are a type of neuroendocrine tumor. They are slow-growing tumors that are usually found in the gastrointestinal system (most often in the rectum and small intestine). Carcinoid tumors may spread to the liver or other sites in the body, and they may secrete substances such as serotonin or prostaglandins, causing carcinoid syndrome.  

Carcinoid Syndrome: A combination of symptoms caused by the release of serotonin and other substances from carcinoid tumors of the gastrointestinal tract. Symptoms may include flushing of the face, flat angiomas (small collections of dilated blood vessels) of the skin, diarrhea, bronchial spasms, rapid pulse, and sudden drops in blood pressure.

Types of Cancer: Melanoma

Melanoma is cancer that begins in cells that become melanocytes, which are specialized cells that make melanin (the pigment that gives skin its color). Most melanomas form on the skin, but melanomas can also form in other pigmented tissues, such as the eye.

Types of Cancer: Multiple Myeloma

Multiple myeloma is cancer that begins in plasma cells, another type of immune cell. The abnormal plasma cells, called myeloma cells, build up in the bone marrow and form tumors in bones all through the body. Multiple myeloma is also called plasma cell myeloma and Kahler disease.

Types of Cancer: Lymphoma

Lymphoma is cancer that begins in lymphocytes (T cells or B cells). These are disease-fighting white blood cells that are part of the immune system. In lymphoma, abnormal lymphocytes build up in lymph nodes and lymph vessels, as well as in other organs of the body.

There are two main types of lymphoma:

  1. Hodgkin lymphoma – People with this disease have abnormal lymphocytes that are called Reed-Sternberg cells. These cells usually form from B cells. 
  2. Non-Hodgkin lymphoma – This is a large group of cancers that start in lymphocytes. The cancers can grow quickly or slowly and can form from B cells or T cells.

Types of Cancer: Leukemia

Cancers that begin in the blood-forming tissue of the bone marrow are called leukemias. These cancers do not form solid tumors. Instead, large numbers of abnormal white blood cells (leukemia cells and leukemic blast cells) build up in the blood and bone marrow, crowding out normal blood cells. The low level of normal blood cells can make it harder for the body to get oxygen to its tissues, control bleeding, or fight infections.

There are four common types of leukemia, which are grouped based on how quickly the disease gets worse (acute or chronic) and on the type of blood cell the cancer starts in (lymphoblastic or myeloid)

Types of Cancer: Sarcoma

Sarcomas are cancers that form in bone and soft tissues, including muscle, fat, blood vessels, lymph vessels, and fibrous tissue (such as tendons and ligaments).


Osteosarcoma is the most common cancer of bone. The most common types of soft tissue sarcoma are leiomyosarcoma, Kaposi sarcoma, malignant fibrous histiocytoma, liposarcoma, and dermatofibrosarcoma protuberans.

Leiomyosarcoma: A malignant (cancer) tumor of smooth muscle cells that can arise almost anywhere in the body, but is most common in the uterus, abdomen, or pelvis.
Kaposi sarcoma: A type of cancer in which lesions (abnormal areas) grow in the skin, lymph nodes, lining of the mouth, nose, and throat, and other tissues of the body. The lesions are usually purple and are made of cancer cells, new blood vessels, and blood cells. They may begin in more than one place in the body at the same time. Kaposi sarcoma is caused by Kaposi sarcoma-associated herpesvirus (KSHV). In the United States, it usually occurs in people who have a weak immune system caused by AIDS or by drugs used in organ transplants. It is also seen in older men of Jewish or Mediterranean descent, or in young men in Africa.
Malignant Fibrous Histiocytoma: A type of cancer that usually forms in the soft tissue, but it may also form in bone. It can occur anywhere in the body, but it usually occurs in the legs (especially the thighs), arms, or back of the abdomen. It may also occur in a part of the body where a patient received radiation therapy in the past. Malignant fibrous histiocytomas often grow quickly and spread to other parts of the body, including the lungs. They usually occur in older adults, and they may sometimes occur as a second cancer in patients who had retinoblastoma. Also called malignant fibrous cytoma and undifferentiated pleomorphic sarcoma.
Dermatofibrosarcoma protuberans: A type of tumor that begins as a hard nodule and grows slowly. These tumors are usually found in the dermis (the inner layer of the two main layers of tissue that make up the skin) of the limbs or trunk of the body. They can grow into surrounding tissue but do not spread to other parts of the body. These tumors are related to giant cell fibroblastomas.

Types of Cancer: Carcinoma

Carcinomas are the most common type of cancer. They are formed by epithelial cells, which are the cells that cover the inside and outside surfaces of the body. There are many types of epithelial cells, which often have a column-like shape when viewed under a microscope.

Carcinomas that begin in different epithelial cell types have specific names:

Adenocarcinoma is a cancer that forms in epithelial cells that produce fluids or mucus. Tissues with this type of epithelial cell are sometimes called glandular tissues. Most cancers of the breast, colon, and prostate are adenocarcinomas.

Basal cell carcinoma is a cancer that begins in the lower or basal (base) layer of the epidermis, which is a person’s outer layer of skin.

Squamous cell carcinoma is a cancer that forms in squamous cells, which are epithelial cells that lie just beneath the outer surface of the skin. Squamous cells also line many other organs, including the stomach, intestines, lungs, bladder, and kidneys. Squamous cells look flat, like fish scales, when viewed under a microscope. Squamous cell carcinomas are sometimes called epidermoid carcinomas.
Transitional cell carcinoma is a cancer that forms in a type of epithelial tissue called transitional epithelium, or urothelium. This tissue, which is made up of many layers of epithelial cells that can get bigger and smaller, is found in the linings of the bladder, ureters, and part of the kidneys (renal pelvis), and a few other organs. Some cancers of the bladder, ureters, and kidneys are transitional cell carcinomas.

Tissue Changes that Are Not Cancer

Not every change in the body’s tissues is cancer. Some tissue changes may develop into cancer if they are not treated, however. Here are some examples of tissue changes that are not cancer but, in some cases, are monitored:

Hyperplasia occurs when cells within a tissue divide faster than normal and extra cells build up, or proliferate. However, the cells and the way the tissue is organized look normal under a microscope. Hyperplasia can be caused by several factors or conditions, including chronic irritation.

Dysplasia is a more serious condition than hyperplasia. In dysplasia, there is also a buildup of extra cells. But the cells look abnormal and there are changes in how the tissue is organized. In general, the more abnormal the cells and tissue look, the greater the chance that cancer will form.

Some types of dysplasia may need to be monitored or treated. An example of dysplasia is an abnormal mole (called a dysplastic nevus) that forms on the skin. A dysplastic nevus can turn into melanoma, although most do not.

An even more serious condition is carcinoma in situ. Although it is sometimes called cancer, carcinoma in situ is not cancer because the abnormal cells do not spread beyond the original tissue. That is, they do not invade nearby tissue the way that cancer cells do. But, because some carcinomas in situ may become cancer, they are usually treated.

When Cancer Spreads

A cancer that has spread from the place where it first started to another place in the body is called metastatic cancer. The process by which cancer cells spread to other parts of the body is called metastasis.
Metastatic cancer has the same name and the same type of cancer cells as the original, or primary, cancer. For example, breast cancer that spreads to and forms a metastatic tumor in the lung is metastatic breast cancer, not lung cancer.

Under a microscope, metastatic cancer cells generally look the same as cells of the original cancer. Moreover, metastatic cancer cells and cells of the original cancer usually have some molecular features in common, such as the presence of specific chromosome changes.

 
Treatment may help prolong the lives of some people with metastatic cancer. In general, though, the primary goal of treatments for metastatic cancer is to control the growth of the cancer or to relieve symptoms caused by it. Metastatic tumors can cause severe damage to how the body functions, and most people who die of cancer die of metastatic disease. 

"Drivers" of Cancer

The genetic changes that contribute to cancer tend to affect three main types of genes—proto-oncogenes, tumor suppressor genes, and DNA repair genes. These changes are sometimes called “drivers” of cancer.
Proto-oncogenes are involved in normal cell growth and division. However, when these genes are altered in certain ways or are more active than normal, they may become cancer-causing genes (or oncogenes), allowing cells to grow and survive when they should not.

Tumor suppressor genes are also involved in controlling cell growth and division. Cells with certain alterations in tumor suppressor genes may divide in an uncontrolled manner.

DNA repair genes are involved in fixing damaged DNA. Cells with mutations in these genes tend to develop additional mutations in other genes. Together, these mutations may cause the cells to become cancerous.
As scientists have learned more about the molecular changes that lead to cancer, they have found that certain mutations commonly occur in many types of cancer. Because of this, cancers are sometimes characterized by the types of genetic alterations that are believed to be driving them, not just by where they develop in the body and how the cancer cells look under the microscope.


A gene involved in normal cell growth. Mutations (changes) in a proto-oncogene may cause it to become an oncogene, which can cause the growth of cancer cells.
 
A type of gene that makes a protein called a tumor suppressor protein that helps control cell growth. Mutations (changes in DNA) in tumor suppressor genes may lead to cancer. Also called antioncogene.
 

How Cancer Arises

Cancer is a genetic disease—that is, it is caused by changes to genes that control the way our cells function, especially how they grow and divide.

Genetic changes that cause cancer can be inherited from our parents. They can also arise during a person’s lifetime as a result of errors that occur as cells divide or because of damage to DNA caused by certain environmental exposures. Cancer-causing environmental exposures include substances, such as the chemicals in tobacco smoke, and radiation, such as ultraviolet rays from the sun.

Each person’s cancer has a unique combination of genetic changes. As the cancer continues to grow, additional changes will occur. Even within the same tumor, different cells may have different genetic changes.
In general, cancer cells have more genetic changes, such as mutations in DNA, than normal cells. Some of these changes may have nothing to do with the cancer; they may be the result of the cancer, rather than its cause.


The molecules inside cells that carry genetic information and pass it from one generation to the next. Also called deoxyribonucleic acid.

Differences between Cancer Cells and Normal Cells

Cancer cells differ from normal cells in many ways that allow them to grow out of control and become invasive. One important difference is that cancer cells are less specialized than normal cells. That is, whereas normal cells mature into very distinct cell types with specific functions, cancer cells do not. This is one reason that, unlike normal cells, cancer cells continue to divide without stopping.

In addition, cancer cells are able to ignore signals that normally tell cells to stop dividing or that begin a process known as programmed cell death, or apoptosis, which the body uses to get rid of unneeded cells.
Cancer cells may be able to influence the normal cells, molecules, and blood vessels that surround and feed a tumor—an area known as the microenvironment. For instance, cancer cells can induce nearby normal cells to form blood vessels that supply tumors with oxygen and nutrients, which they need to grow. These blood vessels also remove waste products from tumors.

Cancer cells are also often able to evade the immune system, a network of organs, tissues, and specialized cells that protects the body from infections and other conditions. Although the immune system normally removes damaged or abnormal cells from the body, some cancer cells are able to “hide” from the immune system.

Tumors can also use the immune system to stay alive and grow. For example, with the help of certain immune system cells that normally prevent a runaway immune response, cancer cells can actually keep the immune system from killing cancer cells.

What Is Cancer?

Collection of Related Diseases

Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues.

Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place.

When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors.
Many cancers form solid tumors, which are masses of tissue. Cancers of the blood, such as leukemias, generally do not form solid tumors.

Cancerous tumors are malignant, which means they can spread into, or invade, nearby tissues. In addition, as these tumors grow, some cancer cells can break off and travel to distant places in the body through the blood or the lymph system and form new tumors far from the original tumor.

Unlike malignant tumors, benign tumors do not spread into, or invade, nearby tissues. Benign tumors can sometimes be quite large, however. When removed, they usually don’t grow back, whereas malignant tumors sometimes do. Unlike most benign tumors elsewhere in the body, benign brain tumors can be life threatening.

Tuesday, January 24, 2017

Book: The Cancer Revolution: A Groundbreaking Program to Reverse and Prevent Cancer by Leigh Erin Connealy

When it comes to cancer, conventional doctors are trained to treat their patients exclusively with surgery, radiation, and chemotherapy. These methods are grueling on the whole body - and they don't treat beyond the tumor or the cancer itself. The focus is on the disease, not the whole person - and because of this, the outcomes in conventional medicine can be bleak.

But it doesn't have to be this way. Dr. Leigh Erin Connealy has developed a whole-person approach to treating cancer - and these treatments have helped thousands of patients through her Cancer Center for Healing. In The Cancer Revolution, Dr. Connealy shows you how to get to the root causes of cancer and the practical steps you can take to get back on the path to healing - from balancing your body's chemistry with nutritional supplements, following a healthy food plan, detoxifying your body and home, exercising regularly, getting deep restful sleep every night, practicing stress reduction techniques, and putting together a supportive healing team.

Chemotherapy and radiation have their place in treatment, but in many cases, they are simply not enough, because cancer isn't caused by one thing, but by many different factors. All of these causes must be addressed, not just the tumor. The Cancer Revolution will equip you to make impactful, achievable lifestyle choices that fight the root of the disease, and that offer hope for recovery and a cancer-free life.